Emergent BioSolutions Inc.
EBSEmergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Drugs in Pipeline
9
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How EBS's past catalysts played out
HuMax-CD4
T Cell Lymphoma
AV7909
Anthrax
ACAM2000
Smallpox Vaccine Adverse Reaction
BioThrax
Anthrax
Dose of 5.0 x 10^9 CFU (Cohort 1)
Typhoid
Vaccinia virus: ACAM2000 smallpox vaccine
Smallpox
FLU-IGIV
Influenza A H3N2
ACAM2000 Smallpox Vaccine
Smallpox
AIGIV 3.5 mg/kg
Anthrax
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
HuMax-CD4 | Phase 3 | T Cell Lymphoma | - | - |
AV7909 | Phase 3 | Anthrax | - | - |
ACAM2000 | Phase 3 | Smallpox Vaccine Adverse Reaction | - | - |
BioThrax | Phase 3 | Anthrax | - | - |
Dose of 5.0 x 10^9 CFU (Cohort 1) | Phase 2 | Typhoid | - | - |
Vaccinia virus: ACAM2000 smallpox vaccine | Phase 2 | Smallpox | - | - |
FLU-IGIV | Phase 2 | Influenza A H3N2 | - | - |
ACAM2000 Smallpox Vaccine | Phase 2 | Smallpox | - | - |
AIGIV 3.5 mg/kg | Phase 2 | Anthrax | - | - |
Frequently asked questions
What is in Emergent BioSolutions Inc.'s drug pipeline?→
CatalystAlert tracks 9 drug candidates in Emergent BioSolutions Inc.'s (EBS) pipeline across Phase 3, Phase 2. Its lead program is HuMax-CD4 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Emergent BioSolutions Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Emergent BioSolutions Inc. (EBS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EBS biotech catalysts?→
Add EBS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Emergent BioSolutions Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.